HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytomegalovirus disease in children with acute lymphoblastic leukemia.

Abstract
Viral infections are an underrecognized problem in children on standard chemotherapy for acute lymphoblastic leukemia (ALL). In countries with high baseline seroprevalence of cytomegalovirus (CMV) such as India, it may be an important pathogen leading to fever, end-organ damage, and cytopenia. Data regarding the incidence and manifestations of CMV disease in pediatric ALL patients are scanty. The authors prospectively assessed all children on chemotherapy for ALL with prolonged febrile neutropenia (FN) for CMV disease over a 3-year period. Children with end-organ damage, including pneumonia, retinitis, and colitis, were also evaluated. Quantitative and qualitative polymerase chain reaction (PCR) from blood, body fluids, or tissue was done along with ophthalmologic evaluation. CMV disease was detected in 10% of the children with prolonged FN. In addition, other children were identified due to end-organ damage, lung and eye being the common organs of involvement. Time of CMV reactivation was essentially during nonintense phase of chemotherapy. Lymphopenia was present in most children, and prolonged lymphopenia was associated with relapse of CMV infection after therapy. The authors conclude that CMV is an important pathogen in children on standard chemotherapy for ALL. It has a good outcome with early detection and directed therapy. Parenteral ganciclovir is needed for a period of 14-21 days to prevent recurrence.
AuthorsRicha Jain, Amita Trehan, Baijyantimala Mishra, Ramandeep Singh, Bhuvan Saud, Deepak Bansal
JournalPediatric hematology and oncology (Pediatr Hematol Oncol) Vol. 33 Issue 4 Pg. 239-47 (May 2016) ISSN: 1521-0669 [Electronic] England
PMID27285991 (Publication Type: Journal Article)
Chemical References
  • Ganciclovir
Topics
  • Child
  • Child, Preschool
  • Cytomegalovirus Infections (drug therapy, etiology)
  • Female
  • Ganciclovir (therapeutic use)
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, drug therapy, virology)
  • Prospective Studies
  • Recurrence
  • Virus Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: